Organization Overview
Alternative names
allogeneic bone marrow (3 trials)
allogeneic cord blood (1 trial)
allogeneic stem cells (1 trial)
alpha-1 antitrypsin (Prolastin) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (5 trials)
autologous cd34+ cells (1 trial)
autologous hematopoietic stem cells (2 trials)
autologous mononuclear stem cell (3 trials)
bortezomib (velcade) (3 trials)
cyclophosphamide (cytoxan) (11 trials)
cyclosporine (sandimmune) (3 trials)
etanercept (enbrel) (2 trials)
fluconazole (diflucan) (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (5 trials)
autologous bone marrow derived cd34+ hsc cells transduced with the lentiviral vector containing a short-hairpin rna targeting bcl11a (1 trial)
bone marrow derived mesenchymal stem cells (2 trials)
dendritic cell tumor fusion vaccine (1 trial)
denileukin diftitox (ontak) (1 trial)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Anemia, Sickle Cell (Phase 2)
Burkitt Lymphoma (Phase 3)
Communicable Diseases (Phase 3)
Epstein-Barr Virus Infections (Phase 2)
Graft vs Host Disease (Phase 3)
Granulomatous Disease, Chronic (Phase 2)
Immune System Diseases (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Infections (Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Multiple Myeloma (Phase 3)
Mycoses (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Plasmablastic Lymphoma (Phase 3)
Pneumonia (Phase 3)
Preleukemia (Phase 3)
Syndrome (Phase 3)
Tissue Adhesions (Phase 2)
Virus Diseases (Phase 2)
